BioDot’s technology is fundamental for modern diagnostics, and its platforms now produce more than 3 billion diagnostic tests worldwide each year. BioDot’s ultra-low-volume, dispensing systems are used to manufacture lateral flow, biosensor, flow through and immunoblot diagnostics.